Morgenthaler — 2013 Investments

2 investments dated 2013 · listed companies and verified rows first · show all

Second Genomesecondgenome.comSeries A · Jun 2013 · $7M

Co-investorsLifeforce Capital Pfizer Venture Investments Digitalis Ventures Lightstone Ventures Roche Venture Fund SR One Capital Management

Vapothermvapotherm.com in 𝕏Apr 2013 · $29M

Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations.

HardwareHealthtechMedical DevicesExeter, US

JOSEPH ARMY(Executive Officer, Director)JOHN LANDRY(Executive Officer)in

BoardANTHONY ARNERICH(Director)JASON LETTMAN(Director)GEOFF PARDO(Director)inSAMUEL BRASCH(Director)

Co-investorsCross Creek Advisors Kaiser Permanente Ventures QuestMark Partners 3x5 Partners Gilde Healthcare

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.